Results 71 to 80 of about 7,910 (224)

Association Between Argatroban and Outcomes of Branch Atheromatous Disease: A Propensity‐Matched Analysis From MRI‐Based Study

CNS Neuroscience &Therapeutics, Volume 31, Issue 6, June 2025.
In patients with branch atheromatous disease‐related stroke, argatroban was not associated with excellent outcome (mRS 0–1) at 90 days, though it was widely used. The risks and benefits of argatroban need reevaluation in this patient population. ABSTRACT Background and Purpose Argatroban is widely used for patients with acute branch atheromatous ...
Shengde Li, Haizhou Hu, Yaping Zhou, Ping Zhang, Guofang Chen, Hongying Bai, Bin Liu, Lixin Zhou, Yicheng Zhu, Bin Peng, Jun Ni, on behalf of BAD‐study investigators   +11 more
wiley   +1 more source

In-Lab Upfront Use of Tirofiban May Reduce the Occurrence of No-Reflow During Primary Percutaneous Coronary Intervention. A Pilot Randomized Study

Arquivos Brasileiros de Cardiologia
Background: Despite successful opening of culprit coronary artery, myocardial reperfusion does not always follows primary percutaneous coronary intervention (PPCI).
Igor Matos Lago, Gustavo Caires Novaes, André Vannucchi Badran, Rafael Brolio Pavão, Ricardo Barbosa, Geraldo Luiz de Figueiredo, Moysés de Oliveira Lima Filho, Jorge Luiz Haddad, André Schmidt, José Antônio Marin Neto   +9 more
doaj   +1 more source

Antithrombotic use in retinal artery occlusion: A narrative review

The Kaohsiung Journal of Medical Sciences, Volume 41, Issue 4, April 2025.
Abstract Retinal artery occlusion (RAO) is a critical ophthalmic emergency with a high risk of significant visual impairment. While traditional treatment aims to promptly restore blood flow to the retina, recent research has investigated the potential benefits of anticoagulation therapy for managing this condition. This paper reviews current literature
Wan‐Yu Liu, Yun‐Hsin Tang, Yi‐Hsing Chen   +2 more
wiley   +1 more source

Association of Anaesthetists guidelines: the use of blood components and their alternatives

Anaesthesia, Volume 80, Issue 4, Page 425-447, April 2025.
Summary Background The administration of blood components and their alternatives can be lifesaving. Anaemia, bleeding and transfusion are all associated with poor peri‐operative outcomes. Considerable changes in the approaches to optimal use of blood components and their alternatives, driven by the findings of large randomised controlled trials and ...
Akshay Shah, Andrew A. Klein, Seema Agarwal, Andrew Lindley, Aamer Ahmed, Kerry Dowling, Emma Jackson, Sumit Das, Divya Raviraj, Rachel Collis, Anna Sharrock, Simon J. Stanworth, Paul Moor   +12 more
wiley   +1 more source

Understanding Drug Interactions in Antiplatelet Therapy for Atherosclerotic Vascular Disease: A Systematic Review

CNS Neuroscience &Therapeutics, Volume 31, Issue 2, February 2025.
Antiplatelet drugs are essential for treating atherosclerotic vascular disease (ASVD), but drug interactions can lead to resistance and affect therapeutic efficacy. Due to the complexity of treatments in ASVD patients, understanding these interactions is critical for optimizing therapy and reducing adverse effects.
Xiangqian Huang, Jiahao Song, Xiaoming Zhang, Mengqi Wang, Yuchuan Ding, Xunming Ji, Da Zhou, Ran Meng   +7 more
wiley   +1 more source

Tirofiban in emergency conditions

The American Journal of Emergency Medicine, 2022
Aleksandra Gasecka, Krzysztof J. Filipiak, Miłosz Jaguszewski, Lukasz Szarpak, Zubaid Rafique   +4 more
openaire   +2 more sources

Tirofiban induced diffuse alveolar hemorrhage

IHJ Cardiovascular Case Reports (CVCR), 2018
Alveolar hemorrhage is a dreaded complication which is seen rarely following the use of tirofiban, it is often confused with other respiratory syndromes resulting in inappropriate or delayed treatment. We present a case of acute alveolar hemorrhage following tirofiban infusion following acute coronary syndrome.
Deepak Kadeli, K S Satish, R Keshava, Nagaraj Aithal   +3 more
openaire   +3 more sources

The safety and efficacy of intra-arterial low-dose tirofiban administration during endovascular therapy in patients with large ischemic core volume

Scientific Reports
This study aimed to evaluate the safety and efficacy of intra-arterial (IA) administration of low- dose tirofiban during endovascular therapy in patients with large ischemic core volumes on initial brain CT. Patients were divided into two groups based on
Kwang-Chun Cho, Nak-Hoon Son, So Hyeon Gwon, Jin Wook Choi, Woo Sang Jung   +4 more
doaj   +1 more source

Cost-effectiveness of tirofiban for acute ischemic stroke without large or medium-sized vessel occlusion: A Markov modelling analysis from the Chinese and United States perspectives.

PLoS ONE
BackgroundThe RESCUE BT2 trial recently showcased the efficacy of tirofiban in treating acute ischemic stroke (AIS) without large or medium-sized vessel occlusion.
Li Wang, Yuhong Zeng, Limei Zhou, Ping Xu, Xianbin Guo, Yu Xie, Junxiu Cai, Min Pan, Jie Tang, Qingtao Gong, Rong Su, Yan Liu, Yake Lou   +12 more
doaj   +1 more source

Tirofiban (Aggrastat®) [PDF]

Cardiovascular Drug Reviews, 1999
Frederick L. Sax and, Eliav Barr, Bohumil Bednar, Mark E. Duggan, Melissa S. Egbertson, Man-Wai Lo, Gail Murphy, Joseph J. Lynch, Jacquelynn J. Cook, Wasyl Halczenko, George D. Hartman, Lawrence I. Deckelbaum, Robert J. Gould   +12 more
openaire   +2 more sources